Subscribe: Reuters: Health News
Added By: Feedage Forager Feedage Grade A rated
Language: English
africa state  approval  coffee  drug companies  drug  health  new york  new  news  reuters  state art  study  washington reuters  year 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Reuters: Health News

Reuters: Health News is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial in


State funding changes in spotlight in Republican healthcare bill

Fri, 22 Sep 2017 06:41:33 -0400

WASHINGTON (Reuters) - Republican leaders sought to nail down the final votes needed to pass what U.S. Vice President Mike Pence on Thursday called their "last best chance" to repeal Obamacare while a new analysis underscored how Democratic-leaning states stand to lose large amounts of federal funding under the legislation.(image)

Japan health minister to consider U.S. drug firms' views in pricing overhaul

Fri, 22 Sep 2017 05:44:43 -0400

TOKYO (Reuters) - Japan will weigh the concerns of U.S. drug firms in its efforts to complete by year-end a drastic revision of its drug-pricing system, aimed at reining in medical spending and cutting the public burden, the health minister said on Friday.(image)

U.S. safety board says train crash engineers had undiagnosed sleep disorder

Thu, 21 Sep 2017 16:16:32 -0400

WASHINGTON (Reuters) - The engineers in two New York City area commuter train crashes suffered from sleep apnea that had not been diagnosed, the U.S. National Transportation Safety Board said on Thursday.(image)

BYU lifts decades-long ban on caffeinated soft drink sales

Thu, 21 Sep 2017 20:09:13 -0400

(Reuters) - Brigham Young University has ended a 60-year ban on the sale of caffeinated soft drinks at its flagship campus in Provo, Utah, the Mormon Church-owned school said on Thursday.(image)

Roche receives EU approval for Gazyvaro, European approval for Actemra

Fri, 22 Sep 2017 01:32:28 -0400

ZURICH (Reuters) - Roche said it has received European approval for its Actemra medication in giant cell arteritis (GCA), the Swiss drugmaker said on Friday.(image)

Versartis growth hormone drug fails key study, shares sink

Thu, 21 Sep 2017 18:00:20 -0400

(Reuters) - Versartis Inc said its experimental drug for the treatment of growth hormone deficiency in children did not meet the main goal of a late-stage study, sending its shares tanking 85 percent.(image)

Many drug companies fail to conduct timely safety checks on medicines after FDA approval

Thu, 21 Sep 2017 12:13:04 -0400

(Reuters Health) - In the rush to approve new medicines, the U.S. Food and Drug Administration often requires drug companies to study possible side effects and alternative doses for medicines once they hit the broader market.(image)

A daily half hour's exercise could prevent 1 in 12 early deaths, study shows

Thu, 21 Sep 2017 19:03:32 -0400

LONDON, Sept 22 (Reuters) - People who exercise five days a week for 30 minutes significantly reduce their risk of dying early and of developing heart disease, even if a sports club or gym is not an option, according to a new international study.(image)

Cans of 'Death Wish' coffee recalled over possible toxin

Thu, 21 Sep 2017 14:37:45 -0400

NEW YORK (Reuters) - Death Wish Coffee Co, a New York coffee maker that sells what it says is the "World's Strongest Coffee," is recalling cans of its Nitro Cold Brew because of the risk that some could contain the deadly toxin botulin.(image)

Exclusive: Africa to get state-of-art HIV drugs for $75 a year

Thu, 21 Sep 2017 06:08:46 -0400

LONDON (Reuters) - Makers of generic AIDS drugs will start churning out millions of pills for Africa containing a state-of-the-art medicine widely used in rich countries, after securing a multi-million dollar guarantee that caps prices at just $75 per patient a year.(image)